-
Antibody production
When you should choose to develop a peptide antibody for your project
The discovery of peptide antibodies has reduced antibody generation costs and increased the specificity of natural monoclonal antibodies. These antibodies remain highly useful for the generation of therapeutic and diagnostic…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Antibody production
Addressing Cross-Reactivity in Antibody Research
Read more -
Antibody production
How to choose the best antibody generation technique for your project?
Read more -
Antibody production
How to generate stable cell lines?
Read more -
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more
-
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more -
Antibody production
Polyclonal vs. Monoclonal antibodies: How to choose the best option for your project?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more